BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Becirovic E. Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04175-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Michurina S, Stafeev I, Boldyreva M, Truong VA, Ratner E, Menshikov M, Hu YC, Parfyonova Y. Transplantation of Adipose-Tissue-Engineered Constructs with CRISPR-Mediated UCP1 Activation. Int J Mol Sci 2023;24. [PMID: 36835254 DOI: 10.3390/ijms24043844] [Reference Citation Analysis]
2 Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 2023;8:36. [PMID: 36646687 DOI: 10.1038/s41392-023-01309-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun T, Xu W, Tu B, Wang T, Liu J, Liu K, Luan Y. Engineered Adipose-Derived Stem Cells Overexpressing RXFP1 via CRISPR Activation Ameliorate Erectile Dysfunction in Diabetic Rats. Antioxidants (Basel) 2023;12. [PMID: 36671033 DOI: 10.3390/antiox12010171] [Reference Citation Analysis]
4 Chang HC, Lee YJ, Javed S, Haque M, Chang YT, Lin YC, Oram C, Huang WH. rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice. J Biol Chem 2023;299:102728. [PMID: 36410433 DOI: 10.1016/j.jbc.2022.102728] [Reference Citation Analysis]